传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2022 IDSA指南：抗菌药物耐药性革兰氏阴性菌感染的治疗（V2.0）

2022-03-31 美国感染病学会 IDSA官网

抗菌药物耐药性革兰氏氏阴性菌

2022年3月，美国感染病学会(IDSA)更新发布了抗菌药物耐药性革兰氏阴性菌感染的治疗指南2.0版。本文主要涉及产AmpC β-内酰胺酶肠杆菌，耐碳青霉烯鲍曼不动杆菌和嗜麦芽寡养单胞菌感染

中文标题：

2022 IDSA指南：抗菌药物耐药性革兰氏阴性菌感染的治疗（V2.0）

英文标题：

IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.0

发布机构：

美国感染病学会

发布日期：

2022-03-31

简要介绍：

2022年3月，美国感染病学会(IDSA)更新发布了抗菌药物耐药性革兰氏阴性菌感染的治疗指南2.0版。本文主要涉及产AmpC β-内酰胺酶肠杆菌，耐碳青霉烯鲍曼不动杆菌和嗜麦芽寡养单胞菌感染的治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 IDSA指南：抗菌药物耐药性革兰氏阴性菌感染的治疗（V2.0）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bd8eb1c002a52605, title=2022 IDSA指南：抗菌药物耐药性革兰氏阴性菌感染的治疗（V2.0）, enTitle=IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.0, guiderFrom=IDSA官网, authorId=0, author=, summary=2022年3月，美国感染病学会(IDSA)更新发布了抗菌药物耐药性革兰氏阴性菌感染的治疗指南2.0版。本文主要涉及产AmpC &beta;-内酰胺酶肠杆菌，耐碳青霉烯鲍曼不动杆菌和嗜麦芽寡养单胞菌感染, cover=https://img.medsci.cn/20220527/1653660688733_1608702.jpg, journalId=0, articlesId=null, associationId=61, associationName=美国感染病学会, associationIntro=美国感染病学会（IDSA）是面向专门从事传染病的医生、科学家和其他医护人员的学会。 核心宗旨是：为临床增加可靠性证据，促进分享以减少传染病给社会带来的经济负担，促进学会成员与其他专业同事之间的合作与交流。, copyright=0, guiderPublishedTime=Thu Mar 31 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年3月，美国感染病学会(IDSA)更新发布了抗菌药物耐药性革兰氏阴性菌感染的治疗指南2.0版。本文主要涉及产AmpC &beta;-内酰胺酶肠杆菌，耐碳青霉烯鲍曼不动杆菌和嗜麦芽寡养单胞菌感染的治疗。</span></p>, tagList=[TagDto(tagId=86081, tagName=抗菌药物耐药性), TagDto(tagId=438555, tagName=革兰氏氏阴性菌)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4199, appHits=99, showAppHits=0, pcHits=1137, showPcHits=4097, likes=2, shares=15, comments=3, approvalStatus=1, publishedTime=Sat May 28 15:09:00 CST 2022, publishedTimeString=2022-03-31, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri May 27 22:15:28 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 15:13:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 IDSA指南：抗菌药物耐药性革兰氏阴性菌感染的治疗（V2.0）.pdf)])
2022 IDSA指南：抗菌药物耐药性革兰氏阴性菌感染的治疗（V2.0）.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2151995, encodeId=226e21519957d, content=学习了，很棒 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/31/4723ee59cf6a3681d6d26892316245cc.jpg, createdBy=6f0f2504475, createdName=DrShen, createdTime=Wed Aug 09 21:31:14 CST 2023, time=2023-08-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223271, encodeId=152a12232e14c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3e76499938, createdName=ms6000001791212108, createdTime=Mon May 30 00:26:12 CST 2022, time=2022-05-30, status=1, ipAttribution=)]
    2023-08-09 DrShen 来自福建省

    学习了，很棒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2151995, encodeId=226e21519957d, content=学习了，很棒 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/31/4723ee59cf6a3681d6d26892316245cc.jpg, createdBy=6f0f2504475, createdName=DrShen, createdTime=Wed Aug 09 21:31:14 CST 2023, time=2023-08-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223271, encodeId=152a12232e14c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3e76499938, createdName=ms6000001791212108, createdTime=Mon May 30 00:26:12 CST 2022, time=2022-05-30, status=1, ipAttribution=)]
    2022-05-30 ms6000001791212108

    学习了

    0